iGMDRD122
Canonical SMILES: C1C(N(C2=C(N1)NC(=NC2=O)N)C=O)CNC3=CC=C(C=C3)C(=O)NC(CCC(=O)O)C(=O)O
InChI: InChI=1S/C20H23N7O7/c21-20-25-16-15(18(32)26-20)27(9-28)12(8-23-16)7-22-11-3-1-10(2-4-11)17(31)24-13(19(33)34)5-6-14(29)30/h1-4,9,12-13,22H,5-8H2,(H,24,31)(H,29,30)(H,33,34)(H4,21,23,25,26,32)/t12-,13-/m0/s1
InChI Key: VVIAGPKUTFNRDU-STQMWFEESA-N
Loading, please wait...
Standard Name | CHEMBL | Pubchem CID | DRUGBANK ID | Drug Status | Drug Type |
---|---|---|---|---|---|
Standard NameLevoleucovorin CHEMBLCHEMBL1908841 Pubchem CID149436 DRUGBANK IDDB11596 Drug StatusAlone Drug TypeSmall Molecule |
Drug Class:
AntidotesBiological FactorsCoenzymesDetoxifying Agents for Antineoplastic TreatmentDiet, Food, and NutritionEnzymes and CoenzymesFolic AcidFoodFood and BeveragesFormyltetrahydrofolatesGrowth SubstancesHeterocyclic CompoundsHeterocyclic Compounds, 2-RingLeucovorinLeucovorin Calcium-LevoleucovorinMicronutrientsPhysiological PhenomenaPigments, BiologicalProtective AgentsPteridinesPterinsSpecialty Uses of ChemicalsTetrahydrofolatesVitamin B ComplexVitaminsDrug-model tissue-cancer distribution: Bubble Plot
Drug-gene pathway enrichments
Drug-gene GO enrichments
Drug-Gene: Aster Plot
Gene in drug-gene network: Network Plot

Models in Levoleucovorin